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Effect of treatment of hyperlipidaemia on haemostatic variables R S ELKELES, R CHAKRABARTI, MARGUERITE VICKERS, YVONNE STIRLING, T W MEADE
Summary and conclusions The haemostatic function of 11 men with hyperlipidaemia was measured before and after they were treated with a carbohydrate-reduced, fat-modified diet. After treatment, which significantly reduced serum triglyceride and cholesterol concentrations, they showed a significant fall in mean levels of clotting factors VII, VIII, and X and a rise in fibrinolytic activity. These findings suggest that haemostatic function may be important in the pathogenesis of ischaemic heart disease.
Introduction
The Northwick Park Heart Study has produced evidence of an association between high concentrations of factor VII, factor VIII, and fibrinogen and an increased risk of later cardiovascular death.' We describe here the changes in these and other haemostatic variables in men who were treated for hyperlipidaemia. 
Patients and methods
Eleven men were studied. Nine were participants in the Northwick Part Heart Study referred for further investigation of hyperlipidaemia found at entry to the study; three of these men were also found to have chemical diabetes on oral glucose tolerance tests. Two known maturity-onset diabetics were also studied. The mean age of the 11 men was 50 years (range 31-65), and their mean body weight before treatment was 76 3 kg.
All the men were treated with a carbohydrate-reduced, fat-modified diet.2 The diets contained 120-150 g carbohydrate and 5 0-6-3 MJ (1200-1500 kcal) a day, depending partly on previous intake. The daily cholesterol intake was about 300 mg. The ratio of polyunsaturated to saturated fats was 1 4:1. Two men also received clofibrate 1 g twice daily. There was no evidence of excess alcohol consumption in any of the men, and they did not change their smoking habits during the study.
Biochemical and haemostatic tests were performed before and after treatment, which lasted a mean of three months (range 1-5). Venous blood was taken through an indwelling cannula between 9 and 10 am after an overnight fast. Serum triglyceride, cholesterol, and blood glucose concentrations were measured by standard enzymatic techniques; data on individual lipoprotein fractions in eight of the men have already been published.3 Fibrinogen and clotting or biological antithrombin activity levels of factors II, V, VII, VIII (denoted VIIIc), and X; III; factor VIII-related antigen (denoted VIIIa); and fibrinolytic activity were measured by methods described elsewhere.4 6 Clotting-factor assays were all carried out against the same standard and values were expressed as percentages of this standard. Fibrinolytic activity was expressed as 100/lysis time in hours.
Results before and after treatment were compared using Student's paired t test (two-tailed).
Results
The findings are shown in the table. There was a sharp reduction in the mean concentration of fasting serum triglycerides and there were also significant reductions in total serum cholesterol and fasting blood glucose concentrations. All clotting factor levels fell and fibrinolytic activity increased, the changes being significant for factors VII, VIIlc, and X and fibrinolytic activity. There was a mean weight loss of 5 kg.
Discussion
In a study of 20 patients with hypertriglyceridaemia treated with phenformin and stanozolol there was a consistent reduction in serum triglyceride concentrations and an increase in fibrinolytic activity, but no other haemostatic variables were studied.6 Hypertriglyceridaemia was also the most obvious abnormality in the men in our study. The relation between serum triglyceride concentrations and the incidence of ischaemic heart disease is less clear than in the case of serum cholesterol. Two prospective studies have found that triglyceride concentrations make an independent contribution to the risk of ischaemic heart disease,7 8 while two have not established this.9 10 The 11 men we studied also had other metabolic abnormalities which are associated with an increased risk of ischaemic heart disease. Besides the very obvious fall in triglyceride concentrations, the treatment was followed by a significant fall in mean serum cholesterol and mean blood glucose concentrations. Our study was not controlled by an untreated group and regression to the mean cannot be excluded as a partial explanation of the results. But the changes in the biochemical variables on the basis of which the men were selected for study were 
SHORT REPORTS Motor neuropathy associated with cimetidine
Reported side effects of cimetidine include arrhythmias,1 thrombocytopenia,2 and coma.3 Peripheral neuropathy, however, has apparently not been described. We report two closely similar cases of motor neuropathy that may have been caused by cimetidine.
Case reports
Case 1-A 44-year-old woman admitted to hospital in status asthmaticus failed to respond to conservative management for 24 hours, and intermittent positive-pressure ventilation was therefore instituted. Over the next five days she improved, treatment including intravenous salbutamol, hydrocortisone 1 g daily, lorazepam, pancuronium, and phenoperidine as required, and cimetidine 200 mg six-hourly as prophylaxis against peptic ulceration. Intermittent positive-pressure ventilation was stopped and treatment changed to oral prednisolone and nebulised salbutamol only. She had developed severe weakness in all limbs, which was most pronounced distally and associated with areflexia. Sensory examination showed nothing abnormal. Within 48 hours motor function began to return, and within four weeks recovery was almost complete. During maximal weakness the cerebrospinal fluid contained no cells, and the protein concentration was 0*3 g/l. There was no detectable increase in serum antibody titre to Mycoplasma, common respiratory viruses, or Coxsackie B viruses.
Case 2-This 29-year-old woman in status asthmaticus failed to respond to conservative measures and began intermittent positive-pressure ventilation 36 hours after admission. Treatment was continued for nine days and included hydrocortisone 1 g daily, subcutaneous terbutaline 0 5 mg sixhourly, nebulised salbutamol, and infusions of aminophylline and cotrimoxazole. Phenoperidine, pancuronium, and diazepam were used as necessary in conventional dosage to permit ventilation and for sedation. Eight days after beginning ventilation she vomited altered blood and was given cimetidine 200 mg six-hourly to a total of seven doses. On stopping ventilation she was found to be weak, most pronounced distally (MRC grades 3-4), and areflexic. Sensory findings were normal. Serum potassium and calcium concentrations were normal, as was creatine phosphokinase activity (53 IU/l; normal 5-100 IU/1). There was no rise in antibody titres to common respiratory viruses or Mycoplasma. Result of the heterophile antibody test was negative. Cerebrospinal fluid was of normal pressure and contained 0 3 g protein/l; no cells were detected, and findings on virus culture were negative. Nerve conduction velocities were normal but the evoked muscle action potential was dispersed and of low amplitude (250 4sV in extensor hallucis brevis). Appearances on concentric needle electromyography-namely, fibrillation potentials, positive sharp waves, and bizarre high-frequency discharges with impaired recruitment-suggested axonal neuropathy. She recovered rapidly, with increase in strength within 48 hours, and recovered fully in eight weeks.
Comment
These patients presented with an exacerbation of longstanding asthma that did not respond to conservative treatment and necessitated
